Skip to content

Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System)

Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System). A Multicentre, Open, Prospective Clinical Investigation. 3 Months Investigation With a 6 Months Follow-up

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01822119
Enrollment
27
Registered
2013-04-02
Start date
2013-03-31
Completion date
2014-02-28
Last updated
2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deafness, Hearing Loss, Hearing Loss, Conductive

Brief summary

The rationale behind this clinical performance investigation is to collect data regarding the usability of the Baha Attract System in patients with hearing impairment that are candidates for Baha surgery: * To describe the expected hearing performance with the Baha Attract in comparison to unaided hearing thresholds or a pre-test situation using a sound processor together with a softband * Which sound processor to select, i.e. BP100 vs BP110 * Improve the fitting process for the sound processor * Selection of sound processor magnet at time of fitting and over time

Interventions

Sponsors

Cochlear Bone Anchored Solutions
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Conductive hearing loss in the implanted ear. Bone conduction thresholds with a pure tone average of 500, 1000, 2000 and 3000 Hz \<30 decibel (dB) hearing level (HL) * Single-sided Sensorineural Deafness (SSD). Bone conduction thresholds with a pure tone average of 500, 1000, 2000 and 3000 Hz \<30 dB hearing level (HL) in the best ear * Signed informed consent

Exclusion criteria

* Uncontrolled diabetes as judged by the investigator * Condition that could jeopardize osseointegration and/or wound healing, e.g. osteoporosis, psoriasis and use of corticosteroids * Unable to follow investigational procedures, e.g. to complete quality of life scales * Less than 4mm of soft tissue pre-operatively * Participation in another investigation with pharmaceuticals and/or device * Condition that may have an impact on the outcome of the investigation as judged by the investigator * Subjects that have received radiation therapy at the same side of the skull where the Baha Attract will be positioned * Suitable implant position for the Baha BI300 implant system (4 mm and 3 mm) not found during surgery due to insufficient bone quality and/or bone thickness

Design outcomes

Primary

MeasureTime frameDescription
Hearing Performance, PTA4 at 12 WeeksBaseline before surgery and 12 weeks after surgeryThe change in pure-tone thresholds in free field measured by the difference in pure tone average PTA4 (Mean of thresholds at 500, 1000, 2000 and 4000 Hz) from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 12.
Hearing Performance, PTA4 at 36 WeeksBaseline before surgery and 36 weeks after surgeryThe change in pure-tone thresholds in free field measured by the difference in pure tone average PTA4 (Mean of thresholds at 500, 1000, 2000 and 4000 Hz) from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.

Secondary

MeasureTime frameDescription
Hearing Performance, Individual FrequenciesBaseline before surgery and 36 weeks after surgeryThe change in pure-tone thresholds in free field measured by the difference at individual frequencies from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.
Hearing Performance, PTA4, Sound Processor on Softband Versus Baha Attract at 36 WeeksBaseline before surgery and 36 weeks after surgeryThe change in pure-tone thresholds in free field measured by the difference in pure tone average PTA4 (Mean of thresholds at 500, 1000, 2000 and 4000 Hz) from the pre-operative aided situation with the Sound Processor on a softband to the aided situation with Baha Attract System at week 36.
Hearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 WeeksBaseline before surgery and 36 weeks after surgeryThe change in pure-tone thresholds in free field measured by the difference in hearing levels of individual frequencies from the pre-operative aided situation with the Sound Processor on a softband to the aided situation with Baha Attract System at week 36.
Hearing Performance, Speech in Quiet, Unaided Versus Baha Attract at 36 WeeksBaseline before surgery and 36 weeks after surgeryThe change in hearing performance, speech in quiet from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.
Hearing Performance, Speech in Quiet, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 WeeksBaseline before surgery and 36 weeks after surgeryThe change in hearing performance, speech in quiet from the pre-operative aided situation with the Sond Processor on a softband to the aided situation with the Baha Attract System at week 36.
Hearing Performance, Speech in Noise, Unaided Versus Baha Attract at 36 WeeksBaseline before surgery and 36 weeks after surgeryThe change in hearing performance, speech in noise from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.
Hearing Performance, Speech in Noise, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 WeeksBaseline before surgery and 36 weeks after surgeryThe change in hearing performance, speech in noise from the pre-operative aided situation with the Sond Processor on a softband to the aided situation with the Baha Attract System at week 36.
Abbreviated Profile of Hearing Aid Benefit (APHAB)Baseline before surgery and 36 weeks after surgeryChange of APHAB scoring from the unaided pre-operative situation to the aided situation with Baha Attract at 36 weeks. APHAB questionnaire is a 24-item self-assessment inventory that evaluates the benefit experienced by the patient when using hearing amplification compared to the unaided situation. APHAB produces a Global score and scores for four subscales: ease of communication (EC), reverberation (RV), background noise (BN), and aversiveness (AV). The absolute APHAB scale is between 0 and 100%, where 0% indicates no problem and 100% indicates always problem. The change from unaided to aided hearing is presented. A positive value indicates an improvement, a negative value an impairment. This scale applies to all reported scores.

Other

MeasureTime frameDescription
Time to Perform SurgeryVisit 2 (surgery)
Tissue Reduction Performed During SurgeryVisit 2 (surgery)Surgical thinning of the soft tissue flap was advocated when the soft tissue thickness exceeded 6 mm.
Implant StabilityVisit 2 (surgery)Implant Stability Quotient - ISQ, a scale from 1 to 100, where 100 represent the highest stability.
Choice of Sound ProcessorBaselineType of sound processors BP100 and BP110 attached to a soft band (subject preference)
Feedback Measurement, BP100Baseline before surgery and 12 weeks after surgeryDifference between softband measurement at visit 1 and measurement with the Baha Attract system at visit 6. Feedback is a measure of how much sound from the actuator (vibrator) returns to the microphones thus creating a loop of sound which sounds like high pitch noise. Measuring this is a part of the performance of the system, i.e how much gain can the sound processor produce before feedback occurs. Unit of measure is dB re output. A negative value of the change means less feedback.
Feedback Measurement, BP110Baseline before surgery and 12 weeks after surgeryDifference between softband measurement at visit 1 and measurement with the Baha Attract system at visit 6. Feedback is a measure of how much sound from the actuator (vibrator) returns to the microphones thus creating a loop of sound which sounds like high pitch noise. Measuring this is a part of the performance of the system, i.e how much gain can the sound processor produce before feedback occurs. Unit of measure is dB re output. A negative value of the change means less feedback.
Magnetic ForceWeek 4, 6, 12 and 36To investigate if the magnetic force required for sound processor magnet retention will change over time
Safety; Skin Evaluation36 weeksEvaluation of the skin using the Patient and Observer Scar Assessment Scale (POSASa scale from 1 (normal skin) to 10 (worst scar imaginable).
Safety; Pain36 weeksEvaluation of neuropathic pain or pain in the scar the last week by asking the patients to rate their experience on a scale from 1 (no, not at all) to 10 (yes, very much).
Safety; Numbness36 weeksEvaluation of numbness by asking the patients if they had experienced any numbness within 2 cm from the centre of the implant magnet or within and beyond 2 cm from the centre of the implant magnet.

Countries

Australia, Chile, Hong Kong, Israel

Participant flow

Participants by arm

ArmCount
Baha Attract System
This transcutaneous solution is based on a magnet coupling using magnets on both side of the skin; * One implant magnet * One external magnet on which a sound processor is attached, i.e. the Sound Processor magnet (SP magnet) Baha Attract System
27
Total27

Baseline characteristics

CharacteristicBaha Attract System
Age, Continuous45.7 years
STANDARD_DEVIATION 13.8
Gender
Female
15 Participants
Gender
Male
12 Participants
Region of Enrollment
Australia
8 participants
Region of Enrollment
Chile
5 participants
Region of Enrollment
Hong Kong
8 participants
Region of Enrollment
Israel
6 participants
Type of hearing loss
Conductive hearing loss
17 participants
Type of hearing loss
Single-sided sensorineural deafness
10 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
8 / 27
serious
Total, serious adverse events
2 / 27

Outcome results

Primary

Hearing Performance, PTA4 at 12 Weeks

The change in pure-tone thresholds in free field measured by the difference in pure tone average PTA4 (Mean of thresholds at 500, 1000, 2000 and 4000 Hz) from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 12.

Time frame: Baseline before surgery and 12 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, PTA4 at 12 Weeks-18.4 dBStandard Deviation 6.7
p-value: <0.0001Fisher's non-parametric permutation
Primary

Hearing Performance, PTA4 at 36 Weeks

The change in pure-tone thresholds in free field measured by the difference in pure tone average PTA4 (Mean of thresholds at 500, 1000, 2000 and 4000 Hz) from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

ArmMeasureValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, PTA4 at 36 Weeks-18.4 dBStandard Deviation 6.9
p-value: <0.0001Fisher's non-parametric permutation
Secondary

Abbreviated Profile of Hearing Aid Benefit (APHAB)

Change of APHAB scoring from the unaided pre-operative situation to the aided situation with Baha Attract at 36 weeks. APHAB questionnaire is a 24-item self-assessment inventory that evaluates the benefit experienced by the patient when using hearing amplification compared to the unaided situation. APHAB produces a Global score and scores for four subscales: ease of communication (EC), reverberation (RV), background noise (BN), and aversiveness (AV). The absolute APHAB scale is between 0 and 100%, where 0% indicates no problem and 100% indicates always problem. The change from unaided to aided hearing is presented. A positive value indicates an improvement, a negative value an impairment. This scale applies to all reported scores.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemAbbreviated Profile of Hearing Aid Benefit (APHAB)Aversiveness-4.04 units on a scaleStandard Deviation 36.03
Baha Attract SystemAbbreviated Profile of Hearing Aid Benefit (APHAB)Ease of communication4.23 units on a scaleStandard Deviation 52.16
Baha Attract SystemAbbreviated Profile of Hearing Aid Benefit (APHAB)Reverberation5.10 units on a scaleStandard Deviation 42.78
Baha Attract SystemAbbreviated Profile of Hearing Aid Benefit (APHAB)Background noise8.92 units on a scaleStandard Deviation 48.07
Baha Attract SystemAbbreviated Profile of Hearing Aid Benefit (APHAB)Global score6.76 units on a scaleStandard Deviation 45.92
Comparison: Aversivenessp-value: 0.59Fisher's non-parametric permutation test
Comparison: Ease of Communicationp-value: 0.71Fisher's non-parametric permutation test
Comparison: Reverberationp-value: 0.59Fisher's non-parametric permutation test
Comparison: Background noisep-value: 0.4Fisher's non-parametric permutation test
Comparison: Global scorep-value: 0.5Fisher's non-parametric permutation test
Secondary

Hearing Performance, Individual Frequencies

The change in pure-tone thresholds in free field measured by the difference at individual frequencies from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, Individual FrequenciesChange in hearing level at 500HZ-20.2 dBStandard Deviation 14.4
Baha Attract SystemHearing Performance, Individual FrequenciesChange in hearing level at 1000HZ-25.2 dBStandard Deviation 8.4
Baha Attract SystemHearing Performance, Individual FrequenciesChange in hearing level at 2000HZ-18.3 dBStandard Deviation 9.5
Baha Attract SystemHearing Performance, Individual FrequenciesChange in hearing level at 3000HZ-18.7 dBStandard Deviation 14.7
Baha Attract SystemHearing Performance, Individual FrequenciesChange in hearing level at 4000HZ-9.8 dBStandard Deviation 10.8
Baha Attract SystemHearing Performance, Individual FrequenciesChange in hearing level at 6000HZ-5.0 dBStandard Deviation 12.3
Baha Attract SystemHearing Performance, Individual FrequenciesChange in hearing level at 8000HZ-4.2 dBStandard Deviation 10.7
Comparison: Statistically significant changes with the same value at 500 to 4000Hzp-value: <0.0001Fisher's non-parametric permutation test
Comparison: Change at 6000Hzp-value: 0.0499Fisher's non-parametric permutation test
Comparison: Change at 8000Hzp-value: 0.0632Fisher's non-parametric permutation test
Secondary

Hearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks

The change in pure-tone thresholds in free field measured by the difference in hearing levels of individual frequencies from the pre-operative aided situation with the Sound Processor on a softband to the aided situation with Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks500Hz-0.741 dBStandard Deviation 13.637
Baha Attract SystemHearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks1000Hz-1.67 dBStandard Deviation 7.34
Baha Attract SystemHearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks2000Hz1.67 dBStandard Deviation 7.07
Baha Attract SystemHearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks3000Hz-0.37 dBStandard Deviation 8.077
Baha Attract SystemHearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks4000Hz4.44 dBStandard Deviation 9.64
Baha Attract SystemHearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks6000Hz6.92 dBStandard Deviation 12.34
Baha Attract SystemHearing Performance, Individual Frequencies, Sound Processor on Softband Versus Baha Attract at 36 Weeks80003.80 dBStandard Deviation 12.1
Comparison: 500Hzp-value: 0.79Fisher's non-parametric permutation test
Comparison: 1000Hzp-value: 0.26Fisher's non-parametric permutation test
Comparison: 2000Hzp-value: 0.24Fisher's non-parametric permutation test
Comparison: 3000Hzp-value: 0.83Fisher's non-parametric permutation test
Comparison: 4000Hzp-value: 0.026Fisher's non-parametric permutation test
Comparison: 6000Hzp-value: 0.0085Fisher's non-parametric permutation test
Comparison: 8000Hzp-value: 0.13Fisher's non-parametric permutation test
Secondary

Hearing Performance, PTA4, Sound Processor on Softband Versus Baha Attract at 36 Weeks

The change in pure-tone thresholds in free field measured by the difference in pure tone average PTA4 (Mean of thresholds at 500, 1000, 2000 and 4000 Hz) from the pre-operative aided situation with the Sound Processor on a softband to the aided situation with Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat population, includes all patients who received surgical intervention.

ArmMeasureValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, PTA4, Sound Processor on Softband Versus Baha Attract at 36 Weeks0.926 dBStandard Deviation 5.553
p-value: 0.39Fisher's non-parametric permutation test
Secondary

Hearing Performance, Speech in Noise, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 Weeks

The change in hearing performance, speech in noise from the pre-operative aided situation with the Sond Processor on a softband to the aided situation with the Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, Speech in Noise, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 Weeks-3.79 Signal to noise ratioStandard Deviation 6.96
p-value: 0.0092Fisher's non-parametric permutation test
Secondary

Hearing Performance, Speech in Noise, Unaided Versus Baha Attract at 36 Weeks

The change in hearing performance, speech in noise from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, Speech in Noise, Unaided Versus Baha Attract at 36 Weeks-15.0 Signal to noise ratioStandard Deviation 12.8
p-value: <0.0001Fisher's non-parametric permutation test
Secondary

Hearing Performance, Speech in Quiet, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 Weeks

The change in hearing performance, speech in quiet from the pre-operative aided situation with the Sond Processor on a softband to the aided situation with the Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, Speech in Quiet, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 WeeksChange at 50dB presentation level2.83 % perception of presented wordsStandard Deviation 23.8
Baha Attract SystemHearing Performance, Speech in Quiet, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 WeeksChange at 65dB presentation level0.98 % perception of presented wordsStandard Deviation 13.49
Baha Attract SystemHearing Performance, Speech in Quiet, Aided With the Sound Processor on a Softband Versus Baha Attract at 36 WeeksChange at 80dB presentation level1.71 % perception of presented wordsStandard Deviation 7.8
Comparison: 50dBp-value: 0.55Fisher's non-parametric permutation test
Comparison: 60dBp-value: 0.72Fisher's non-parametric permutation test
Comparison: 80dBp-value: 0.28Fisher's non-parametric permutation test
Secondary

Hearing Performance, Speech in Quiet, Unaided Versus Baha Attract at 36 Weeks

The change in hearing performance, speech in quiet from the pre-operative unaided condition to the aided situation with the Baha Attract System at week 36.

Time frame: Baseline before surgery and 36 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemHearing Performance, Speech in Quiet, Unaided Versus Baha Attract at 36 WeeksChange at 50dB presentation level50 % perception of presented wordsStandard Deviation 23.7
Baha Attract SystemHearing Performance, Speech in Quiet, Unaided Versus Baha Attract at 36 WeeksChange at 65dB presentation level46.4 % perception of presented wordsStandard Deviation 31.7
Baha Attract SystemHearing Performance, Speech in Quiet, Unaided Versus Baha Attract at 36 WeeksChange at 80dB presentation level24.2 % perception of presented wordsStandard Deviation 25.6
Comparison: Statistically significant improvement with the same value at all presentation levels.p-value: <0.0001Fisher's non-parametric permutation test
Other Pre-specified

Choice of Sound Processor

Type of sound processors BP100 and BP110 attached to a soft band (subject preference)

Time frame: Baseline

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (NUMBER)
Baha Attract SystemChoice of Sound ProcessorBP1006 participants
Baha Attract SystemChoice of Sound ProcessorBP11021 participants
Other Pre-specified

Feedback Measurement, BP100

Difference between softband measurement at visit 1 and measurement with the Baha Attract system at visit 6. Feedback is a measure of how much sound from the actuator (vibrator) returns to the microphones thus creating a loop of sound which sounds like high pitch noise. Measuring this is a part of the performance of the system, i.e how much gain can the sound processor produce before feedback occurs. Unit of measure is dB re output. A negative value of the change means less feedback.

Time frame: Baseline before surgery and 12 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemFeedback Measurement, BP1001250Hz-10.1 dBStandard Deviation 2.4
Baha Attract SystemFeedback Measurement, BP100400Hz-13.2 dBStandard Deviation 7.8
Baha Attract SystemFeedback Measurement, BP100500Hz-6.54 dBStandard Deviation 3.98
Baha Attract SystemFeedback Measurement, BP100630Hz-4.29 dBStandard Deviation 8.56
Baha Attract SystemFeedback Measurement, BP100800Hz-7.11 dBStandard Deviation 6.84
Baha Attract SystemFeedback Measurement, BP1001000Hz-7.85 dBStandard Deviation 4.59
Baha Attract SystemFeedback Measurement, BP1001600Hz-7.44 dBStandard Deviation 2.88
Baha Attract SystemFeedback Measurement, BP1002000Hz-2.82 dBStandard Deviation 1.59
Baha Attract SystemFeedback Measurement, BP1002500Hz-2.91 dBStandard Deviation 3.64
Baha Attract SystemFeedback Measurement, BP1003150Hz-1.21 dBStandard Deviation 3.66
Baha Attract SystemFeedback Measurement, BP1004000Hz1.83 dBStandard Deviation 3.42
Baha Attract SystemFeedback Measurement, BP1005000Hz0.17 dBStandard Deviation 4.37
Baha Attract SystemFeedback Measurement, BP1006300Hz7.28 dBStandard Deviation 7.62
Baha Attract SystemFeedback Measurement, BP1008000Hz3.95 dBStandard Deviation 3.26
Other Pre-specified

Feedback Measurement, BP110

Difference between softband measurement at visit 1 and measurement with the Baha Attract system at visit 6. Feedback is a measure of how much sound from the actuator (vibrator) returns to the microphones thus creating a loop of sound which sounds like high pitch noise. Measuring this is a part of the performance of the system, i.e how much gain can the sound processor produce before feedback occurs. Unit of measure is dB re output. A negative value of the change means less feedback.

Time frame: Baseline before surgery and 12 weeks after surgery

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemFeedback Measurement, BP110400Hz-3.50 dBStandard Deviation 8.36
Baha Attract SystemFeedback Measurement, BP110500Hz-3.86 dBStandard Deviation 8.46
Baha Attract SystemFeedback Measurement, BP110630Hz-4.20 dBStandard Deviation 10.59
Baha Attract SystemFeedback Measurement, BP110800Hz-3.39 dBStandard Deviation 9.16
Baha Attract SystemFeedback Measurement, BP1101000Hz-5.03 dBStandard Deviation 7.17
Baha Attract SystemFeedback Measurement, BP1101250Hz-8.10 dBStandard Deviation 7.87
Baha Attract SystemFeedback Measurement, BP1101600Hz-8.85 dBStandard Deviation 6.51
Baha Attract SystemFeedback Measurement, BP1102000Hz-4.73 dBStandard Deviation 4.65
Baha Attract SystemFeedback Measurement, BP1102500Hz-3.08 dBStandard Deviation 4.1
Baha Attract SystemFeedback Measurement, BP1103150Hz-3.00 dBStandard Deviation 3.3
Baha Attract SystemFeedback Measurement, BP1104000Hz0.69 dBStandard Deviation 4.86
Baha Attract SystemFeedback Measurement, BP1105000Hz6.58 dBStandard Deviation 6.24
Baha Attract SystemFeedback Measurement, BP1106300Hz10.3 dBStandard Deviation 4.7
Baha Attract SystemFeedback Measurement, BP1108000Hz12.2 dBStandard Deviation 9.7
Other Pre-specified

Implant Stability

Implant Stability Quotient - ISQ, a scale from 1 to 100, where 100 represent the highest stability.

Time frame: Visit 2 (surgery)

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureValue (MEAN)Dispersion
Baha Attract SystemImplant Stability75.7 units on a scaleStandard Deviation 8.8
Other Pre-specified

Magnetic Force

To investigate if the magnetic force required for sound processor magnet retention will change over time

Time frame: Week 4, 6, 12 and 36

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemMagnetic Force4 weeks0.97 NewtonStandard Deviation 0.3
Baha Attract SystemMagnetic Force6 weeks1.05 NewtonStandard Deviation 0.37
Baha Attract SystemMagnetic Force12 weeks0.98 NewtonStandard Deviation 0.29
Baha Attract SystemMagnetic Force36 weeks0.97 NewtonStandard Deviation 0.28
Other Pre-specified

Safety; Numbness

Evaluation of numbness by asking the patients if they had experienced any numbness within 2 cm from the centre of the implant magnet or within and beyond 2 cm from the centre of the implant magnet.

Time frame: 36 weeks

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (NUMBER)
Baha Attract SystemSafety; NumbnessNo numbness21 participants
Baha Attract SystemSafety; NumbnessNumbness within 2 cm1 participants
Baha Attract SystemSafety; NumbnessNumbness within 2 cm and beyond5 participants
Other Pre-specified

Safety; Pain

Evaluation of neuropathic pain or pain in the scar the last week by asking the patients to rate their experience on a scale from 1 (no, not at all) to 10 (yes, very much).

Time frame: 36 weeks

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemSafety; PainNeuropathic pain1.19 units on a scaleStandard Deviation 0.79
Baha Attract SystemSafety; PainPain in the scar1.15 units on a scaleStandard Deviation 0.77
Other Pre-specified

Safety; Skin Evaluation

Evaluation of the skin using the Patient and Observer Scar Assessment Scale (POSASa scale from 1 (normal skin) to 10 (worst scar imaginable).

Time frame: 36 weeks

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Baha Attract SystemSafety; Skin EvaluationOverall opinion observer1.52 units on a scaleStandard Deviation 0.93
Baha Attract SystemSafety; Skin EvaluationOverall opinion patient1.81 units on a scaleStandard Deviation 1.21
Other Pre-specified

Time to Perform Surgery

Time frame: Visit 2 (surgery)

Population: Intention-to-Treat (ITT) population, includes all patients who received surgical intervention.

ArmMeasureValue (MEAN)Dispersion
Baha Attract SystemTime to Perform Surgery45.0 minutesStandard Deviation 14.6
Other Pre-specified

Tissue Reduction Performed During Surgery

Surgical thinning of the soft tissue flap was advocated when the soft tissue thickness exceeded 6 mm.

Time frame: Visit 2 (surgery)

Population: Intention-to-Treat population, includes all patients who received surgical intervention.

ArmMeasureGroupValue (NUMBER)
Baha Attract SystemTissue Reduction Performed During SurgeryNo tissue reduction24 participants
Baha Attract SystemTissue Reduction Performed During SurgeryTissue reduction3 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026